What is testosterone replacement therapy?

Testosterone replacement therapy (TRT) is a physician-supervised treatment that restores testosterone to a level appropriate for an individual patient. It is typically considered for men who have both symptoms consistent with low testosterone and lab values that confirm deficiency, though the decision to initiate therapy always depends on the full clinical picture.

TRT is not a shortcut to peak fitness, and it is not a lifestyle intervention. It is a medical therapy with specific indications, contraindications, and monitoring requirements. Every patient we evaluate is treated as an individual, and TRT is only recommended when the risk-benefit balance is clearly favorable.

How testosterone works in the body

Testosterone is a hormone produced primarily in the testes, regulated by a feedback loop involving the hypothalamus and pituitary gland. It plays a role in maintaining muscle mass, bone density, red blood cell production, libido, mood, and metabolic function. Levels naturally decline with age — typically about 1% per year after age 30 — but symptomatic deficiency requiring treatment is not a universal outcome of aging.

Common signs that may prompt evaluation

Men who ultimately test low often report a combination of the following, though none of these individually confirm a hormonal cause:

• Persistent fatigue despite adequate sleep
• Reduced libido or erectile changes
• Loss of muscle mass or strength despite training
• Increased body fat, particularly around the midsection
• Mood changes, including low motivation or irritability
• Difficulty concentrating

These symptoms can also reflect thyroid dysfunction, sleep apnea, depression, or other conditions. A proper workup rules these out.

How we evaluate

Our evaluation begins with a comprehensive lab panel drawn in the morning (when testosterone is highest). We typically test total testosterone, free testosterone, SHBG, LH, FSH, estradiol, prolactin, PSA (in men over 40), CBC, a metabolic panel, and lipids. We do not diagnose based on a single value — we look at trends, symptoms, and rule out reversible causes first.

Formats of TRT

When treatment is indicated, several delivery methods are available. Each has trade-offs:

• Injections (testosterone cypionate, most common): typically weekly or twice weekly, subcutaneous or intramuscular.
• Pellets: implanted every 3–6 months, no daily action required.
• Topical creams or gels: applied daily, useful for men who prefer to avoid injections.
• Oral options: newer formulations that avoid liver toxicity concerns of older oral agents.

Selection depends on lifestyle, tolerance, cost, and clinical goals.

What to expect during treatment

Response varies. Some men notice changes in energy and mood within 3–6 weeks. Changes in body composition typically take 3–6 months of consistent therapy combined with resistance training. Sexual symptoms often improve gradually over the first several months.

TRT is not a substitute for sleep, nutrition, or exercise — patients who improve most consistently are those who address foundational health alongside therapy.

Monitoring and safety

Ongoing monitoring is not optional. We repeat labs at 6 weeks, 3 months, 6 months, then every 6–12 months thereafter. We watch hematocrit (red blood cell concentration), PSA, estradiol, and clinical response. Dose adjustments are common in the first year.

TRT is generally not appropriate for men with untreated prostate cancer, severe untreated sleep apnea, uncontrolled heart failure, or those actively trying to conceive without fertility-preserving co-therapy.

Common questions

Is TRT permanent? Once initiated, natural production is typically suppressed. Stopping requires either accepting return of baseline symptoms or a supervised restart protocol.

Does TRT affect fertility? Yes — it typically suppresses sperm production. Men who want to preserve fertility should discuss alternative approaches such as HCG, clomiphene, or enclomiphene before starting TRT.

Is it safe long-term? Current evidence, appropriately monitored, does not show increased cardiovascular or prostate cancer risk in men with genuine deficiency. But safety depends on proper selection, dosing, and ongoing monitoring — not on the medication itself in isolation.

Next steps

If you’re experiencing symptoms that may be hormone-related, the first step is a proper evaluation, not a shortcut to therapy. Book a consultation and we’ll start with the diagnostics.